MYLIP and breast cancer: The data showed that over-expression of miR-19b and inhibition of MYLIP could significantly reduce the relative gap distances at 48h compared with the control groups (*p < 0.05, **p < 0.01) (Figure 4B, 4C), which facilitates the migration capacities of breast cancer cells.